NYSE:ABBV

AbbVie Earnings Date, Estimates & History

$85.87

-1.27 (-1.46 %)

(As of 09/24/2020 10:40 AM ET)

Add

Compare

Today's Range

$85.61

Now: $85.87▼

$87.29

50-Day Range

$88.60

MA: $92.81▼

$96.35

52-Week Range

$62.55

Now: $85.87▼

$101.28

Volume112,228 shs

Average Volume7.28 million shs

Market Capitalization$151.55 billion

P/E Ratio18.27

Dividend Yield5.33%

Beta0.75

AbbVie (NYSE:ABBV) Earnings Information

AbbVie last issued its quarterly earnings data on July 31st, 2020. The reported $2.34 EPS for the quarter, topping the consensus estimate of $2.20 by $0.14. The firm earned $10.43 billion during the quarter, compared to the consensus estimate of $10.14 billion. Its quarterly revenue was up 26.3% compared to the same quarter last year. AbbVie has generated $8.94 earnings per share over the last year and currently has a price-to-earnings ratio of 18.3. AbbVie has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 6th, 2020 based off prior year's report dates.

AbbVie Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AbbVie (NYSE:ABBV) Earnings Estimates

2020 EPS Consensus Estimate: $9.98
2021 EPS Consensus Estimate: $11.96

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2020	4	$2.20	$2.28	$2.25
Q2 2020	4	$2.17	$2.50	$2.37
Q3 2020	4	$2.37	$2.87	$2.63
Q4 2020	4	$2.46	$3.04	$2.72
Q1 2021	1	$2.83	$2.83	$2.83
Q2 2021	1	$2.94	$2.94	$2.94
Q3 2021	1	$3.03	$3.03	$3.03
Q4 2021	1	$3.16	$3.16	$3.16

AbbVie (NYSE ABBV) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Reported EPS	GAAP EPS	Revenue Estimate	Actual Revenue	Conference Call
11/6/2020 (Estimated)
7/31/2020	6/30/2020	$2.20	$2.34	$5.14	$10.14 billion	$10.43 billion	Transcript
5/1/2020	3/31/2020	$2.25	$2.42	$2.82	$8.31 billion	$8.62 billion	Transcript
2/7/2020	12/31/2019	$2.19	$2.21	$2.54	$8.68 billion	$8.70 billion	Transcript
11/1/2019	Q3 2019	$2.29	$2.33	$3.40	$8.37 billion	$8.48 billion	Transcript
7/26/2019	Q2 2019	$2.21	$2.26	$4.03	$8.09 billion	$8.26 billion	Listen
4/25/2019	Q1 2019	$2.06	$2.14	$2.63	$7.81 billion	$7.83 billion	Listen
1/25/2019	12/31/2018	$1.92	$1.90	$5.03	$8.37 billion	$8.31 billion	Listen
11/2/2018	9/30/2018	$2.01	$2.14	$2.47	$8.23 billion	$8.24 billion	N/A
7/27/2018	6/30/2018	$1.98	$2.00	$2.74	$8.22 billion	$8.28 billion	N/A
4/26/2018	Q1 2018	$1.79	$1.87	$2.00	$7.60 billion	$7.93 billion	N/A

1/26/2018	Q4 2017	$1.44	$1.48	$2.93	$7.53 billion	$7.74 billion	Transcript
10/27/2017	Q3 2017	$1.39	$1.41	$1.81	$7.00 billion	$7.00 billion	N/A
7/28/2017	Q2 2017	$1.40	$1.42	$1.65	$6.93 billion	$6.94 billion	N/A
4/27/2017	Q1 2017	$1.2620	$1.28	$1.50	$6.49 billion	$6.54 billion	N/A
1/27/2017	Q416	$1.20	$1.20	$1.55	$6.92 billion	$6.78 billion	Listen
10/28/2016	Q316	$1.21	$1.21	$1.45	$6.55 billion	$6.43 billion	Listen
7/29/2016	Q216	$1.20	$1.26	$1.54	$6.20 billion	$6.43 billion	Listen
4/28/2016	Q116	$1.14	$1.15	$1.47	$6.03 billion	$5.96 billion	Listen
1/29/2016	Q415	$1.12	$1.13	$1.34	$6.41 billion	$6.36 billion	Listen
10/30/2015	Q315	$1.08	$1.13	$1.52	$5.90 billion	$4.94 billion	Listen
7/24/2015	Q215	$1.06	$1.08	$1.33	$5.60 billion	$5.48 billion	Listen
4/23/2015	Q115	$0.85	$0.94	$1.25	$718.50 million	$5.04 billion	Listen
1/30/2015	Q414	$0.86	$0.89	$2.29	$5.34 billion	$5.45 billion	Listen
10/31/2014	Q3	$0.77	$0.89	$1.47	$4.82 million	$5.02 million	Listen
7/25/2014	Q214	$0.76	$0.82	$0.96	$4.70 billion	$4.93 billion	Listen
4/25/2014	Q114	$0.68	$0.71	$0.83	$4.33 billion	$4.56 billion	Listen
1/31/2014	Q4 2013	$0.83	$0.82	$0.94	$5.10 billion	$5.11 billion	Listen
10/25/2013	Q3 2013	$0.78	$0.82	$1.04	$4.52 billion	$4.66 billion	Listen
7/26/2013	Q2 2013	$0.79	$0.82	$0.98	$4.54 billion	$4.69 billion	Listen
4/26/2013	Q1 2013	$0.66	$0.68	$0.76	$4.17 billion	$4.33 billion	Listen

(Earnings results data provided by Zacks Investment Research)

This page was last updated on 9/24/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

AbbVie Earnings Date, Estimates & History

Adding

Adding

Adding AbbVie Inc

Earnings

AbbVie (NYSE:ABBV) Earnings Information

AbbVie Earnings Estimates and Actuals by Quarter

AbbVie (NYSE:ABBV) Earnings Estimates

AbbVie (NYSE ABBV) Earnings History by Quarter

30 Days of MarketBeat All Access for $1.00

Options Trading from Scratch

Market Data and Calendars

Investing Education and Resources